Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study
Genomic research had been widely expected to transform medicine, but progress has been slower than some have expected. To critics delays represent broken promises and/or a sign that at least some of the money spent on genomic research might have been better spent elsewhere.
More description
Genomic research had been widely expected to transform medicine, but progress has been slower than some have expected. To critics delays represent broken promises and/or a sign that at least some of the money spent on genomic research might have been better spent elsewhere.
2013-04-01
9 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.